TSOI Stock - Therapeutic Solutions International, Inc.
Unlock GoAI Insights for TSOI
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Revenue | $98,994 | $206,767 | $145,956 | $62,681 | $27,495 |
| Gross Profit | $62,226 | $127,327 | $103,412 | $49,889 | $24,480 |
| Gross Margin | 62.9% | 61.6% | 70.9% | 79.6% | 89.0% |
| Operating Income | $-1,986,479 | $-3,279,377 | $-2,304,346 | $-1,849,580 | $-1,043,166 |
| Net Income | $-2,169,814 | $-3,813,981 | $-2,961,445 | $-2,199,901 | $-1,697,322 |
| Net Margin | -2191.9% | -1844.6% | -2029.0% | -3509.7% | -6173.2% |
| EPS | $-0.00 | $-0.00 | $-0.00 | $-0.00 | $-0.00 |
Therapeutic Solutions International, Inc. focuses on immune modulation for the treatment of various specific diseases. The company develops a range of immune-modulatory agents to cancers, schizophrenia, suicidal ideation, traumatic brain injury, and lung pathologies, as well as for daily health. Its flagship products include QuadraMune, a patented synergistic blend of pterostilbene, sulforaphane, epigallocatechingallate, and thymoquionone to increase natural killer cell activity and healthy cytokine production. The company also produces nutraceuticals, including ProJuvenol, a synergistic blend of complex anti-aging ingredients in capsules; NanoStilbene, a nanoemulsion of nanoparticle pterostilbene; DermalStilbene, a topical form of pterostilbene delivered through spray application onto skin; IsoStilbene, an injectable formulation of pterostilbene; NeuroStilbene, an intranasal form of pterostilbene; NanoPlus, a blend of NanoStilbene and Nano Cannabidiol; Nano Cannabidiol, a nanoparticle formulation of cannabidiol; NanoPSA, a blend of NanoStilbene and broccoli sprout extract; and NLRP3 Trifecta, a two-product combo that consists of one bottle of NanoPSA and one bottle of GTE-50 green tea extract. It is also developing therapeutics in chronic traumatic encephalopathy, and traumatic brain injury and lung pathology. Therapeutic Solutions International, Inc. was founded in 2007 and is based in Elk City, Idaho.
Visit WebsiteEarnings History & Surprises
TSOIEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Nov 18, 2025 | — | — | — | — |
Q3 2025 | Aug 22, 2025 | — | — | — | — |
Q2 2025 | May 29, 2025 | — | — | — | — |
Q4 2024 | Nov 22, 2024 | — | $-0.00 | — | — |
Q3 2024 | Aug 19, 2024 | — | $-0.00 | — | — |
Q2 2024 | May 30, 2024 | — | $-0.15 | — | — |
Q2 2024 | Apr 17, 2024 | — | $-0.00 | — | — |
Q4 2023 | Nov 14, 2023 | — | $-0.18 | — | — |
Q3 2023 | Aug 21, 2023 | — | $-0.00 | — | — |
Q2 2023 | May 16, 2023 | — | $-0.10 | — | — |
Q1 2023 | Mar 29, 2023 | — | $-0.00 | — | — |
Q4 2022 | Nov 17, 2022 | — | $-0.00 | — | — |
Q3 2022 | Aug 19, 2022 | — | $-0.00 | — | — |
Q2 2022 | May 23, 2022 | — | $-0.00 | — | — |
Q1 2022 | Mar 31, 2022 | — | $-0.00 | — | — |
Q4 2021 | Nov 22, 2021 | — | $-0.00 | — | — |
Q3 2021 | Aug 13, 2021 | — | $-0.00 | — | — |
Q2 2021 | May 17, 2021 | — | $-0.00 | — | — |
Q2 2021 | Apr 9, 2021 | — | $-0.00 | — | — |
Q4 2020 | Nov 19, 2020 | — | $-0.00 | — | — |
Latest News
Frequently Asked Questions about TSOI
What is TSOI's current stock price?
What is the analyst price target for TSOI?
What sector is Therapeutic Solutions International, Inc. in?
What is TSOI's market cap?
Does TSOI pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to TSOI for comparison